Table 1 Baseline-characteristics compared completers and non-completers of the study
From: Multiple risk factor intervention reduces carotid atherosclerosis in patients with type 2 diabetes
|  | Completers (n = 77) | Non-completers (n = 20) | p-value |
|---|---|---|---|
Sex (female/male) | 27/50 | 9/11 | 0.001 |
Age (years) | 60 ± 8 | 65 ± 10 | 0.048 |
Height (cm) | 170 ± 9 | 167 ± 9 | 0.061 |
Weight (kg) | 91 ± 15 | 91 ± 18 | 0.989 |
Smokers | 25 (25.8%) | 8 (40%) | 0.002 |
Packyears (years) | 31 (12 – 56) | 26 (10 -58) | 0.599 |
Hip circumference (cm) | 113 ± 9 | 112 ± 9 | 0.717 |
Waist circumference (cm) | 109 ± 12 | 107 ± 13 | 0.396 |
Blood pressure systolic (mmHg) | 154 ± 17 | 146 ± 19 | 0.138 |
Blood pressure diastolic (mmHg) | 90 ± 9 | 88 ± 11 | 0.473 |
Duration of diabetes mellitus (years) | 7.7 ± 6.8 | 7.5 ± 5.4 | 0.897 |
HbA1c % (mmol/mol) | 8.2 ± 1.1% (66 ± 12) | 8.6 ± 0.7% (70 ± 8) | 0.049 |
Total cholesterol (mmol/l) | 4.93 ± 1.11 | 5.02 ± 1.11 | 0.785 |
Low density lipoproteins (mmol/l) | 2.79 ± 1.11 | 2.79 ± 1.12 | 0.937 |
High density lipoproteins (mmol/l) | 1.14 ± 0.36 | 1.11 ± 0.46 | 0.738 |
CIMT (mm) | 0.883 ± 0.120 | 0.875 ± 0.171 | 0.840 |
RHI | 1.70 (1.46 – 2.08) | 1.72 (1.38 – 2.07) | 0.590 |
CD133 + VEGF-R2 (per 106 lymphomonocytes) | 15 (7 – 28) | 14 (5 – 21) | 0.514 |
ADMA (μM/L) | 0.625 ± 0.080 | 0.606 ± 0.082 | 0.313 |
SDMA (μM/L) | 0.562 ± 0.131 | 0.543 ± 0.110 | 0.445 |
Serum creatinine (μmol/l) | 88.4 ± 26.5 | 84.0 ± 36.0 | 0.604 |
Alanin-Aminotransferase (U/l) | 29 (21 – 40) | 24 (21 – 39) | 0.836 |
Gamma Glutamyltransferase (U/l) | 35 (21 – 59) | 28 (21 – 38) | 0.824 |
Aspartat-Aminotransferase (U/l) | 27 (21 – 36) | 49 (28 – 91) | 0.246 |